Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ALK
    (1)
  • Adrenergic Receptor
    (1)
  • HCV Protease
    (1)
  • Ligands for E3 Ligase
    (1)
  • Molecular Glues
    (1)
  • Transferase
    (1)
  • Others
    (7)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (1)
  • Endocrine system
    (1)
  • Infection
    (1)
Filter
Search Result
Results for "

or 611

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    12
    TargetMol | All_Pathways
  • PROTAC Products
    2
    TargetMol | PROTAC
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Antibody Products
    18
    TargetMol | Antibody_Products
  • Oligonucleotides
    1
    TargetMol | All_Pathways
Entacapone
OR-611, 116314-67-1
T2216130929-57-6
Entacapone is a potent and specific peripheral catechol-O-methyltransferase (COMT) inhibitor with an IC50 of 151 nM. Entacapone is also a potential obesity-related gene (FTO) inhibitor that can inhibit FTO demethylation activity and be used in the study of metabolic diseases.
  • $30
In Stock
Size
QTY
RGW 611
T20206497-78-5
RGW 611, a morpholine derivative, enhances radiation effects and induces cell death in hypoxic V79-379A cells.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CRBN ligand-611
T2167512766179-60-4
CRBN ligand-611 is an E3 ubiquitin ligase cereblon (CRBN) ligand that facilitates the recruitment of cereblon proteins. This compound can be linked to a target protein ligand via a linker to form a PROTAC.
  • Inquiry Price
Inquiry
Size
QTY
TRI-611
T2175273117940-39-0
TRI-611 is an oral, blood-brain barrier-penetrating ALK molecular chaperone degrader. TRI-611 specifically binds to E3 ligases, recruits and marks oncogenic ALK fusion proteins, and mediates their selective degradation via the ubiquitin-proteasome system. TRI-611 induces tumor regression in xenograft models of ALK-positive NSCLC. TRI-611 is equally effective in TKI-resistant tumor models. TRI-611 is suitable for use in studies of ALK-positive non-small cell lung cancer and TKI-resistant tumors.
  • $68
2-4 weeks
Size
QTY
T-611 free base
T-902611, T-611, T-2611, T2611, T-0902611, T0902611
T28905350595-60-7
T-611, a cytomegalovirus replication inhibitor, is used potentially for the treatment of cytomegalovirus infections.
  • $1,520
6-8 weeks
Size
QTY
MS611
MS-611, MS 611
T33512
MS611 is a BET bromine domain inhibitor that shows high selectivity only for BD in the BRD4 bromine domain.
  • Inquiry Price
3-6 months
Size
QTY
NK 611
NK-611, NK611
T33695105760-98-3
NK 611 is a new semisynthetic analogue of etoposide and has been found to be more potent against several cancer cell lines in vitro than etoposide.
  • Inquiry Price
3-6 months
Size
QTY
AL-611
T390821613591-70-0
AL-611 is an HCV NS5B polymerase inhibitor (EC50 = 5 nM).
  • $970
Inquiry
Size
QTY
HPR-611
T6934936857-46-2
HPR-611 is a potent inhibitor of anaphylactic chemical mediator release.
  • $1,520
6-8 weeks
Size
QTY
NK-611 free acid
T71521105655-99-0
NK-611 free acid is a new semisynthetic analogue of etoposide, which presumably also acts through inhibition of topoisomerase II, and has been found to be more potent against several cancer cell lines in vitro than etoposide.
  • $1,520
6-8 weeks
Size
QTY
Naftopidil
KT-611, BM-15275
T069657149-07-2
Naftopidil (KT-611) (INN, marketed under the brand name Flivas), an antihypertensive medicine, is used as a selective α1-adrenergic receptor antagonist or α-blocker.
  • $40
In Stock
Size
QTY
Bromhexine-D3 hydrochloride
TMIJ-0339
Bromhexine-D3 hydrochloride is a deuterated compound of Bromhexine Hydrochloride (T0828). Bromhexine hydrochloride has a CAS number of 611-75-6. Bromhexine hydrochloride is a mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus.
  • Inquiry Price
20 days
Size
QTY